Moderna’s Patent Settlement Clears Path ForwardBusiness PenMarch 4, 2026April 22, 2026 March 4, 2026April 22, 2026 [stock_market_widget type=”card” template=”basic2″ assets=”MRNA” realtime=”true” api=”yahoo-finance”] Moderna, Inc. (NASDAQ: MRNA) has built its name on messenger RNA, or mRNA, technology. This approach instructs cells to...